The Acute Respiratory Distress Syndrome (ARDS) is a devastating clinical condition that is
associated with a 30–40% risk of death, and significant long term morbidity for those who …

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been a major public health challenge …

Objectives: Mesenchymal stem cells–based therapies have shown promising effects in
experimental acute respiratory distress syndrome. Different mesenchymal stem cells …

With the recognition of obesity as a global health crisis, researchers have devoted greater
effort to defining and understanding the pathophysiological molecular pathways regulating …

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are characterized by
pulmonary edema attributable to alveolar epithelial–interstitial–endothelial injury …

Multiple sclerosis is an autoimmune disease that affects the white matter of the central
nervous system and involves inflammation and demyelination. The recent advances in our …

Mesenchymal stromal cells (MSCs) are a potential therapy for many chronic inflammatory
diseases due to their regenerative, immunologic and anti-inflammatory properties. The two …

Adipose stem cells (ASCs) have gained attention in the fields of stem cells regenerative
medicine due to their multifaceted therapeutic capabilities. Promising preclinical evidence of …

MSCs have become an emerging cell source with their immune modulation, high
proliferation rate, and differentiation potential; indeed, they have been challenged in clinical …

Abstract Background SARS-CoV-2, which majorly affects the lungs and respiratory tract is
thought due to dysregulation of the immune system which causes an immense imbalance of …